Literature DB >> 2822314

Delayed hypersensitivity skin testing and anergy in a population of gay men.

S D Sears1, R Fox, R Brookmeyer, R Leavitt, B F Polk.   

Abstract

Anergy is almost universal among patients with the acquired immunodeficiency syndrome (AIDS). To determine the prevalence and correlates of anergy in a population at risk for AIDS, we performed skin tests in 1120 gay men who were enrolled in a prospective study of the natural history of human immunodeficiency virus (HIV) infection. Anergy, defined as no induration to any of four intradermal antigens, was present in 12%. Individually, no induration was detected in response to tetanus toxoid (41%), mumps (28%), candida (47%), and trichophyton (72%). Anergy was strongly associated with the presence of antibody to HIV and with a reduced number of T helper lymphocytes, but not independently with generalized lymphadenopathy, the number of reported male sexual partners in the previous 2 years, the number of T suppressor lymphocytes, or with high titers of antibodies to cytomegalovirus. Nine percent of HIV antibody-negative subjects and 20% of antibody-positive subjects were anergic; anergy is not specific for serologically documented HIV infection in this population. Skin testing with only tetanus toxoid, candida, and mumps antigens may be sufficient to detect anergy. In the presence of HIV antibody, the ability of anergy to predict progressive immunodeficiency remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822314     DOI: 10.1016/0090-1229(87)90032-8

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  4 in total

1.  Performance of antigens used in detecting delayed-type hypersensitivity in adolescents infected with the human immunodeficiency virus.

Authors:  A S Rogers; J H Ellenberg; S D Douglas; L Henry-Reid; L Peralta; C M Wilson
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

2.  Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type 1-infected patients from Spain in the era of highly active antiretroviral therapy.

Authors:  Rafael de La Rosa; Juan A Pineda; Juan Delgado; Juan Macías; Francisco Morillas; José A Mira; Armando Sánchez-Quijano; Manuel Leal; Eduardo Lissen
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

3.  Anergy compromises screening for tuberculosis in high-risk populations.

Authors:  S R Zoloth; S Safyer; J Rosen; D Michaels; P Alcabes; E Bellin; C Braslow
Journal:  Am J Public Health       Date:  1993-05       Impact factor: 9.308

4.  Five year prospective study of HIV infection in the Edinburgh haemophiliac cohort.

Authors:  R J Cuthbert; C A Ludlam; J Tucker; C M Steel; D Beatson; S Rebus; J F Peutherer
Journal:  BMJ       Date:  1990-10-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.